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Background
The supporting stroma of breast cancer is believed to
support the growth and metastasis of cancer cells and
are responsible for suppressing anti-cancer immune
responses. In this regard we attempted to isolate and
characterise the cancer associated fibroblasts (CAFs) of
murine model of spontaneously developed breast cancer.
Methods
CAFs were isolated by explants culture of tumour tissue.
The Fibroblast activated protein-alpha( FAP-a)-positive
fibroblasts were co-cultured with splenocytes where the
splenocyte proliferation and production of inflammatory
and regulatory cytokines were assessed by ELISA. Also the
inflammatory enzymes iNOS and the production of matrix
metaloproteinases 2 and 9 by these cells were evaluated
using Real-Time PCR.
Results
Findings indicated enhanced in vitro immune suppres-
sion in co-cultures of CAF and splenocyte. Additionally,
increased regulatory cytokine and inflammatory media-
tors was observed.
Conclusion
The secretory profile of these cells, as the supporting
matrix, is a massive physical and immune barrier to anti-
cancer immune therapy. Therefore it is proposed for
enhancing the effect of therapy must take into acount the
contribution of cancer associated fibroblasts on the
chronic inflammatory microenvironment of breast cancer.
Authors’ details
1Tarbiat Modares University, Immunology, Tehran, Iran. 2Tarbiat Modares
University, Haematology, Tehran, Iran. 3Stem Cell Technology Center, Stem
Cell Biology, Tehran, Iran.
Published: 12 March 2014
doi:10.1186/2051-1426-2-S2-P17
Cite this article as: Langroudi et al.: P26. Cancer associated fibroblasts
contribute to the immune suppression of breast cancer by
augmentation of the inflammatory products. Journal for ImmunoTherapy
of Cancer 2014 2(Suppl 2):P17.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1Tarbiat Modares University, Immunology, Tehran, Iran
Full list of author information is available at the end of the article
Langroudi et al. Journal for ImmunoTherapy of Cancer 2014, 2(Suppl 2):P17
http://www.immunotherapyofcancer.org/content/2/S2/P17
© 2014 Langroudi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
